These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Heitman J; Movva NR; Hall MN Science; 1991 Aug; 253(5022):905-9. PubMed ID: 1715094 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the FK506 binding domain of human FKBP25 in complex with FK506. Prakash A; Rajan S; Yoon HS Protein Sci; 2016 Apr; 25(4):905-10. PubMed ID: 26749369 [TBL] [Abstract][Full Text] [Related]
9. Heteronuclear 3D NMR studies of water bound to an FK506 binding protein/immunosuppressant complex. Xu RX; Meadows RP; Fesik SW Biochemistry; 1993 Mar; 32(10):2473-80. PubMed ID: 7680570 [TBL] [Abstract][Full Text] [Related]
10. FK506 and the role of immunophilins in nerve regeneration. Gold BG Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703 [TBL] [Abstract][Full Text] [Related]
11. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553 [TBL] [Abstract][Full Text] [Related]
12. Solution structure of FK506 bound to FKBP-12. Lepre CA; Thomson JA; Moore JM FEBS Lett; 1992 May; 302(1):89-96. PubMed ID: 1375171 [TBL] [Abstract][Full Text] [Related]
13. FKBP family proteins: immunophilins with versatile biological functions. Kang CB; Hong Y; Dhe-Paganon S; Yoon HS Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947 [TBL] [Abstract][Full Text] [Related]
14. Exon organization of the human FKBP-12 gene: correlation with structural and functional protein domains. DiLella AG; Craig RJ Biochemistry; 1991 Sep; 30(35):8512-7. PubMed ID: 1716149 [TBL] [Abstract][Full Text] [Related]
15. pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands. Yu L; Fesik SW Biochim Biophys Acta; 1994 Nov; 1209(1):24-32. PubMed ID: 7524680 [TBL] [Abstract][Full Text] [Related]
16. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). Itoh S; Navia MA Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622 [TBL] [Abstract][Full Text] [Related]
17. Solution structure of FK506 bound to the R42K, H87V double mutant of FKBP-12. Lepre CA; Pearlman DA; Cheng JW; DeCenzo MT; Livingston DJ; Moore JM Biochemistry; 1994 Nov; 33(46):13571-80. PubMed ID: 7524662 [TBL] [Abstract][Full Text] [Related]
18. NMR studies of an FK-506 analogue, [U-13C]ascomycin, bound to FKBP: conformation and regions of ascomycin involved in binding. Petros AM; Gampe RT; Gemmecker G; Neri P; Holzman TF; Edalji R; Hochlowski J; Jackson M; McAlpine J; Luly JR J Med Chem; 1991 Sep; 34(9):2925-8. PubMed ID: 1716684 [No Abstract] [Full Text] [Related]
19. Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR. Petros AM; Kawai M; Luly JR; Fesik SW FEBS Lett; 1992 Aug; 308(3):309-14. PubMed ID: 1380470 [TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. Meadows RP; Nettesheim DG; Xu RX; Olejniczak ET; Petros AM; Holzman TF; Severin J; Gubbins E; Smith H; Fesik SW Biochemistry; 1993 Jan; 32(3):754-65. PubMed ID: 7678499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]